{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:33:52Z","timestamp":1783794832918,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04626-6","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:03:35Z","timestamp":1759219415000},"page":"3461-3476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial"],"prefix":"10.1007","volume":"399","author":[{"given":"Musarrat","family":"Zahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozina","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"4626_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8398","author":"SA Arslanian","year":"2002","unstructured":"Arslanian SA, Lewy V, Danadian K, Saad R (2002) Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.87.4.8398","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1874091X00802010108","volume":"2","author":"CR Assump\u00e7\u00e3o","year":"2008","unstructured":"Assump\u00e7\u00e3o CR, Brunini TMC, Matsuura C et al (2008) Impact of the L-arginine-nitric oxide pathway and oxidative stress on the pathogenesis of the metabolic syndrome. Open Biochem J 2:108","journal-title":"Open Biochem J"},{"key":"4626_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17446651.2018.1434412","volume":"13","author":"RS Auriemma","year":"2018","unstructured":"Auriemma RS, De Alcubierre D, Pirchio R et al (2018) The effects of hyperprolactinemia and its control on metabolic diseases. Expert Rev Endocrinol Metab 13:99\u2013106. https:\/\/doi.org\/10.1080\/17446651.2018.1434412","journal-title":"Expert Rev Endocrinol Metab"},{"key":"4626_CR4","doi-asserted-by":"publisher","first-page":"1188839","DOI":"10.3389\/fnins.2023.1188839","volume":"17","author":"S Bagheri","year":"2023","unstructured":"Bagheri S, Haddadi R, Saki S et al (2023) Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Front Neurosci 17:1188839. https:\/\/doi.org\/10.3389\/fnins.2023.1188839","journal-title":"Front Neurosci"},{"key":"4626_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03459.x","author":"M Barba","year":"2009","unstructured":"Barba M, Schunemann HJ, Sperati F et al (2009) The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03459.x","journal-title":"Clin Endocrinol"},{"key":"4626_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S (2021) Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 95:531\u2013541. https:\/\/doi.org\/10.1111\/cen.14421","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4626_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1477-7525-11-141","volume":"11","author":"F Bazarganipour","year":"2013","unstructured":"Bazarganipour F, Ziaei S, Montazeri A et al (2013) Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes 11:141. https:\/\/doi.org\/10.1186\/1477-7525-11-141","journal-title":"Health Qual Life Outcomes"},{"key":"4626_CR8","first-page":"61","volume":"13","author":"F Bazarganipour","year":"2015","unstructured":"Bazarganipour F, Taghavi SA, Montazeri A et al (2015) The impact of polycystic ovary syndrome on the health-related quality of life: a systematic review and meta-analysis. Iran J Reprod Med 13:61","journal-title":"Iran J Reprod Med"},{"key":"4626_CR9","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3390\/cells11203255","volume":"11","author":"E Carmina","year":"2022","unstructured":"Carmina E, Longo RA (2022) Increased prevalence of elevated DHEAS in PCOS women with non-classic (B or C) phenotypes: a retrospective analysis in patients aged 20 to 29 years. Cells 11:3255. https:\/\/doi.org\/10.3390\/cells11203255","journal-title":"Cells"},{"key":"4626_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/9781108989831.008","volume-title":"Polycystic Ovary Syndrome","author":"O Celik","year":"2022","unstructured":"Celik O, Yildiz BO (2022) Adrenal and Polycystic Ovary Syndrome. In: Fauser B, Kovacs GT, Legro RS (eds) Polycystic Ovary Syndrome, 3rd edn. Cambridge University Press, Cambridge, pp 67\u201379","edition":"3"},{"key":"4626_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/IJWH.S345853","volume":"14","author":"X Cheng","year":"2022","unstructured":"Cheng X, He B (2022) Clinical and biochemical potential of antioxidants in treating polycystic ovary syndrome. Int J Womens Health 14:467\u2013479. https:\/\/doi.org\/10.2147\/IJWH.S345853","journal-title":"Int J Womens Health"},{"key":"4626_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F et al (2021) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol"},{"key":"4626_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270\u2013284","journal-title":"Nat Rev Endocrinol"},{"key":"4626_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00228-023-03461-z","volume":"79","author":"AFS Fontes","year":"2023","unstructured":"Fontes AFS, Reis FM, C\u00e2ndido AL et al (2023) Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Eur J Clin Pharmacol 79:445\u2013460. https:\/\/doi.org\/10.1007\/s00228-023-03461-z","journal-title":"Eur J Clin Pharmacol"},{"key":"4626_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2265.1995.tb00541.x","volume":"43","author":"MC Foss","year":"1995","unstructured":"Foss MC, Paula FJA, Paccola GMGF, Piccinato CE (1995) Peripheral glucose metabolism in human hyperprolactinaemia. Clin Endocrinol (Oxf) 43:721\u2013726. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb00541.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4626_CR16","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1210\/en.2003-1446","volume":"145","author":"T Fujikawa","year":"2004","unstructured":"Fujikawa T, Soya H, Tamashiro KL et al (2004) Prolactin prevents acute stress-induced hypocalcemia and ulcerogenesis by acting in the brain of rat. Endocrinology 145:2006\u20132013","journal-title":"Endocrinology"},{"key":"4626_CR17","first-page":"56","volume":"1","author":"AD Genazzani","year":"2020","unstructured":"Genazzani AD, Prati A, Genazzani AR et al (2020) Synergistic effects of the integrative administration of acetyl-L-carnitine, L-carnitine, L-arginine and N-acetyl-cysteine on metabolic dynamics and on hepatic insulin extraction in overweight\/obese patients with PCOS. Gynecological and Reproductive Endocrinology & Metabolism 1:56\u201363","journal-title":"Gynecological and Reproductive Endocrinology & Metabolism"},{"key":"4626_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/biomedicines10061455","volume":"10","author":"D Glintborg","year":"2022","unstructured":"Glintborg D, Kolster ND, Ravn P, Andersen MS (2022a) Prospective risk of type 2 diabetes in normal weight women with polycystic ovary syndrome. Biomedicines 10:1455. https:\/\/doi.org\/10.3390\/biomedicines10061455","journal-title":"Biomedicines"},{"key":"4626_CR19","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/biomedicines10061455","volume":"10","author":"D Glintborg","year":"2022","unstructured":"Glintborg D, Kolster ND, Ravn P, Andersen MS (2022b) Prospective risk of type 2 diabetes in normal weight women with polycystic ovary syndrome. Biomedicines 10:1455","journal-title":"Biomedicines"},{"key":"4626_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/antiox10040520","volume":"10","author":"A Hidalgo-Guti\u00e9rrez","year":"2021","unstructured":"Hidalgo-Guti\u00e9rrez A, Gonz\u00e1lez-Garc\u00eda P, D\u00edaz-Casado ME et al (2021) Metabolic targets of coenzyme Q10 in mitochondria. Antioxidants 10:520","journal-title":"Antioxidants"},{"key":"4626_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/oxfordjournals.humrep.a138480","volume":"9","author":"SG Hillier","year":"1994","unstructured":"Hillier SG (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 9:188\u2013191. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138480","journal-title":"Hum Reprod"},{"key":"4626_CR22","first-page":"2696","volume":"10","author":"M Hu","year":"2018","unstructured":"Hu M, Li J, Zhang Y et al (2018) Endometrial progesterone receptor isoforms in women with polycystic ovary syndrome. Am J Transl Res 10:2696","journal-title":"Am J Transl Res"},{"key":"4626_CR23","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16410","volume":"11","author":"X Hu","year":"2023","unstructured":"Hu X, Wang W, Su X et al (2023) Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis. PeerJ 11:e16410. https:\/\/doi.org\/10.7717\/peerj.16410","journal-title":"PeerJ"},{"key":"4626_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","volume":"61","author":"L Ibanez","year":"2017","unstructured":"Ibanez L, Del R\u00edo L, D\u00edaz M et al (2017) Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome. J Adolesc Health 61:446\u2013453","journal-title":"J Adolesc Health"},{"key":"4626_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12586","volume":"15","author":"L Ib\u00e1\u00f1ez","year":"2020","unstructured":"Ib\u00e1\u00f1ez L, De Zegher F (2020) Polycystic ovary syndrome in adolescent girls. Pediatr Obes 15:e12586. https:\/\/doi.org\/10.1111\/ijpo.12586","journal-title":"Pediatr Obes"},{"key":"4626_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179362","author":"S Ito","year":"2025","unstructured":"Ito S, Taguchi K, Kodama G et al (2025) Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.179362","journal-title":"JCI Insight"},{"key":"4626_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1210\/jc.2018-01221","volume":"104","author":"A Izadi","year":"2019","unstructured":"Izadi A, Ebrahimi S, Shirazi S et al (2019) Hormonal and metabolic effects of coenzyme Q10 and\/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 104:319\u2013327. https:\/\/doi.org\/10.1210\/jc.2018-01221","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR28","first-page":"53","volume":"29","author":"A Jafarzadeh Esfehani","year":"2020","unstructured":"Jafarzadeh Esfehani A et al (2020) L-arginine supplementation improves sex hormone-binding globulin and reduces inflammation in women with polycystic ovary syndrome. J Womens Health 29:53\u201359","journal-title":"J Womens Health"},{"key":"4626_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1071\/RD18131","volume":"31","author":"Z Kalhori","year":"2019","unstructured":"Kalhori Z, Mehranjani MS, Azadbakht M, Shariatzadeh MA (2019a) L-carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. Reprod Fertil Dev 31:282\u2013293","journal-title":"Reprod Fertil Dev"},{"key":"4626_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1071\/RD18131","volume":"31","author":"Z Kalhori","year":"2019","unstructured":"Kalhori Z, Mehranjani MS, Azadbakht M, Shariatzadeh MA (2019b) L-carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. Reprod Fertil Dev 31:282\u2013293. https:\/\/doi.org\/10.1071\/RD18131","journal-title":"Reprod Fertil Dev"},{"key":"4626_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43043-022-00121-7","volume":"27","author":"M Kazeminia","year":"2022","unstructured":"Kazeminia M, Rajati F, Rajati M (2022) The effect of exercise on anti-Mullerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Middle East Fertil Soc J 27:31. https:\/\/doi.org\/10.1186\/s43043-022-00121-7","journal-title":"Middle East Fertil Soc J"},{"key":"4626_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.110851","volume":"134","author":"SE Kelek","year":"2019","unstructured":"Kelek SE, Af\u015far E, Ak\u00e7ay G et al (2019) Effect of chronic L-carnitine supplementation on carnitine levels, oxidative stress and apoptotic markers in peripheral organs of adult Wistar rats. Food Chem Toxicol 134:110851","journal-title":"Food Chem Toxicol"},{"key":"4626_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175474","volume":"12","author":"R Krysiak","year":"2023","unstructured":"Krysiak R, Kowalcze K, Szkr\u00f3bka W, Okopie\u0144 B (2023) Impaired prolactin-lowering effects of metformin in women with polycystic ovary syndrome. J Clin Med 12:5474","journal-title":"J Clin Med"},{"key":"4626_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/nu17040665","volume":"17","author":"N Kurhaluk","year":"2025","unstructured":"Kurhaluk N, Tkaczenko H (2025) L-arginine and nitric oxide in vascular regulation\u2014experimental findings in the context of blood donation. Nutrients 17:665","journal-title":"Nutrients"},{"key":"4626_CR35","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1210\/jc.2015-2778","volume":"100","author":"RS Legro","year":"2015","unstructured":"Legro RS, Dodson WC, Kris-Etherton PM et al (2015) Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J Clin Endocrinol Metab 100:4048\u20134058. https:\/\/doi.org\/10.1210\/jc.2015-2778","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1423-0127-19-32","volume":"19","author":"J-L Li","year":"2012","unstructured":"Li J-L, Wang Q-Y, Luan H-Y et al (2012) Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha. J Biomed Sci 19:32. https:\/\/doi.org\/10.1186\/1423-0127-19-32","journal-title":"J Biomed Sci"},{"key":"4626_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1423-0127-21-2","volume":"21","author":"X Li","year":"2014","unstructured":"Li X, Feng Y, Lin J-F et al (2014) Endometrial progesterone resistance and PCOS. J Biomed Sci 21:2. https:\/\/doi.org\/10.1186\/1423-0127-21-2","journal-title":"J Biomed Sci"},{"key":"4626_CR38","first-page":"359","volume":"178","author":"M Mansourian","year":"2018","unstructured":"Mansourian M et al (2018) L-carnitine supplementation reduces oxidative stress and improves insulin sensitivity in women with polycystic ovary syndrome. Eur J Endocrinol 178:359\u2013367","journal-title":"Eur J Endocrinol"},{"key":"4626_CR39","doi-asserted-by":"crossref","unstructured":"Moinard C, Breuillard C, Charrueau C (2017) l-Arginine Metabolism Impairment in Sepsis and Diseases: Causes and Consequences. In: Patel VB, Preedy VR, Rajendram R (eds) L-Arginine in Clinical Nutrition. Springer International Publishing, Cham, pp 145\u2013158","DOI":"10.1007\/978-3-319-26009-9_12"},{"key":"4626_CR40","first-page":"3469","volume":"102","author":"MF Mojtahedi","year":"2017","unstructured":"Mojtahedi MF et al (2017) Metformin and L-carnitine supplementation improves insulin sensitivity and reduces oxidative stress in women with polycystic ovary syndrome. J Clin Endocrinol Metab 102:3469\u20133478","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1053\/meta.2002.35181","volume":"51","author":"DM M\u00fcller","year":"2002","unstructured":"M\u00fcller DM, Seim H, Kiess W et al (2002) Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism 51:1389\u20131391. https:\/\/doi.org\/10.1053\/meta.2002.35181","journal-title":"Metabolism"},{"key":"4626_CR42","doi-asserted-by":"publisher","first-page":"1271521","DOI":"10.3389\/fendo.2023.1271521","volume":"14","author":"A Patani","year":"2023","unstructured":"Patani A, Balram D, Yadav VK et al (2023) Harnessing the power of nutritional antioxidants against adrenal hormone imbalance-associated oxidative stress. Front Endocrinol 14:1271521. https:\/\/doi.org\/10.3389\/fendo.2023.1271521","journal-title":"Front Endocrinol"},{"key":"4626_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD (2010) Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high? REPRODUCTION 139:825\u2013833. https:\/\/doi.org\/10.1530\/REP-09-0415","journal-title":"REPRODUCTION"},{"key":"4626_CR44","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/biomedicines10081924","volume":"10","author":"T Petrillo","year":"2022","unstructured":"Petrillo T, Semprini E, Tomatis V et al (2022) Putative complementary compounds to counteract insulin-resistance in PCOS patients. Biomedicines 10:1924","journal-title":"Biomedicines"},{"key":"4626_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","volume":"23","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D et al (2022) Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 23:583. https:\/\/doi.org\/10.3390\/ijms23020583","journal-title":"Int J Mol Sci"},{"key":"4626_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2288-4-26","volume":"4","author":"M Saghaei","year":"2004","unstructured":"Saghaei M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4:26. https:\/\/doi.org\/10.1186\/1471-2288-4-26","journal-title":"BMC Med Res Methodol"},{"key":"4626_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","volume":"31","author":"S Sahmay","year":"2014","unstructured":"Sahmay S, Aydin Y, Oncul M, Senturk LM (2014) Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet 31:213\u2013220. https:\/\/doi.org\/10.1007\/s10815-013-0149-0","journal-title":"J Assist Reprod Genet"},{"key":"4626_CR48","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","volume":"60","author":"S Sam","year":"2017","unstructured":"Sam S, Ehrmann DA (2017) Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia 60:1656\u20131661. https:\/\/doi.org\/10.1007\/s00125-017-4306-3","journal-title":"Diabetologia"},{"key":"4626_CR49","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi FA et al (2016) Expression of concern\u202f: Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 84:851\u2013857. https:\/\/doi.org\/10.1111\/cen.13003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4626_CR50","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cen.13288","volume":"86","author":"M Samimi","year":"2017","unstructured":"Samimi M, Zarezade Mehrizi M, Foroozanfard F et al (2017) The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 86:560\u2013566. https:\/\/doi.org\/10.1111\/cen.13288","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4626_CR51","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00394-021-02659-0","volume":"61","author":"AA Sangouni","year":"2022","unstructured":"Sangouni AA, Pakravanfar F, Ghadiri-Anari A et al (2022) The effect of l-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight\/obese women with polycystic ovary syndrome: a randomized clinical trial. Eur J Nutr 61:1199\u20131207. https:\/\/doi.org\/10.1007\/s00394-021-02659-0","journal-title":"Eur J Nutr"},{"issue":"4","key":"4626_CR52","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1210\/jcem.83.4.4710","volume":"83","author":"I Schipper","year":"1998","unstructured":"Schipper I, Hop WCJ, Fauser BCJM (1998) The follicle-stimulating hormone (FSH) threshold\/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development1. J Clin Endocrinol Metab 83(4):1292\u20131298. https:\/\/doi.org\/10.1210\/jcem.83.4.4710","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR53","doi-asserted-by":"publisher","unstructured":"Shah FA, Bukhari SMS, Emal E, Shah M (2025) Effects of integrative administration of acetyl-L-carnitine, arginine, and Co-Q10 in mitigating oxidative stress in over-weight\/obese PCOS women. J Appl Pharm Sci 15:274\u2013282. https:\/\/doi.org\/10.7324\/JAPS.2025.70521","DOI":"10.7324\/JAPS.2025.70521"},{"key":"4626_CR54","doi-asserted-by":"publisher","unstructured":"Silva SV e, Gallia MC, da Luz JRD et al (2022) Antioxidant effect of coenzyme Q10 in the prevention of oxidative stress in arsenic-treated CHO-K1 cells and possible participation of zinc as a pro-oxidant agent. Nutrients 14:3265. https:\/\/doi.org\/10.3390\/nu14163265","DOI":"10.3390\/nu14163265"},{"key":"4626_CR55","doi-asserted-by":"crossref","unstructured":"Sidra S, Tariq MH, Farrukh MJ, Mohsin M (2019) Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PloS One 14(10):e0223329. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0223329. Accessed 20 May 2025","DOI":"10.1371\/journal.pone.0223329"},{"key":"4626_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-015-0272-4","volume":"15","author":"SA Taghavi","year":"2015","unstructured":"Taghavi SA, Bazarganipour F, Hugh-Jones S, Hosseini N (2015) Health-related quality of life in Iranian women with polycystic ovary syndrome: a qualitative study. BMC Womens Health 15:111. https:\/\/doi.org\/10.1186\/s12905-015-0272-4","journal-title":"BMC Womens Health"},{"key":"4626_CR57","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJ et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 189:G43\u2013G64","journal-title":"Eur J Endocrinol"},{"key":"4626_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G, Bazer FW, Davis TA et al (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153\u2013168. https:\/\/doi.org\/10.1007\/s00726-008-0210-y","journal-title":"Amino Acids"},{"key":"4626_CR59","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.biopha.2018.10.128","volume":"109","author":"F Xiong","year":"2019","unstructured":"Xiong F, Xiao J, Bai Y et al (2019) Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases. Biomed Pharmacother 109:1578\u20131585","journal-title":"Biomed Pharmacother"},{"key":"4626_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.690539","author":"MXC Yin","year":"2021","unstructured":"Yin MXC, Du LB, Zou XN et al (2021) Can psychosocial intervention suppress testosterone and triglycerides among women with polycystic ovary syndrome? A feasibility trial. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2021.690539","journal-title":"Front Psychol"},{"key":"4626_CR61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Y, Liu Y et al (2020) Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta 502:214\u2013221","journal-title":"Clin Chim Acta"},{"key":"4626_CR62","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/09513590.2021.1926975","volume":"37","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xing C, Zhao H, He B (2021) The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network meta-analysis. Gynecol Endocrinol 37:1063\u20131071. https:\/\/doi.org\/10.1080\/09513590.2021.1926975","journal-title":"Gynecol Endocrinol"},{"key":"4626_CR63","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s43032-022-01038-2","volume":"30","author":"T Zhang","year":"2023","unstructured":"Zhang T, He Q, Xiu H et al (2023) Efficacy and safety of coenzyme Q10 supplementation in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Sci 30:1033\u20131048. https:\/\/doi.org\/10.1007\/s43032-022-01038-2","journal-title":"Reprod Sci"},{"key":"4626_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0037-1603096","volume":"35","author":"T Zore","year":"2017","unstructured":"Zore T, Joshi N, Lizneva D, Azziz R (2017) Polycystic ovarian syndrome: long-term health consequences. Semin Reprod Med 35:271\u2013281. https:\/\/doi.org\/10.1055\/s-0037-1603096","journal-title":"Semin Reprod Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04626-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:59:32Z","timestamp":1772006372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04626-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4626"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04626-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants in this study were informed about the research objectives, potential risks, and benefits of the research. Written informed consent was obtained from each participant before to their inclusion in the study. The study was conducted in accordance with the ethical guidelines outlined in the Declaration of Helsinki, and ethical approval was obtained from the Khyber Medical University ethics committee. (Approval No. DIR\/KMU-EB\/IA\/000838). Participants were assured of confidentiality, and their data were used solely for research purposes. They had the right to withdraw from the study at any stage without any consequences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from ethical committee of Khyber and its Advanced Study and Research Board (Approval No. DIR\/KMU-AS&RB\/IA\/001202). Written informed consent was obtained from all participants, and the trial was registered under ClinicalTrials.gov (NCT05653895).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}